Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂)

yf_tkr_DHR · 2026-08-25

$MASI $DHR $ROOT $DCO

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510(k) clearance for the Masimo Root® with LiDCO® hemodynamic monitoring solution, including the Masimo LiDCO sensor. This comprehensive solution provides the unique ability to continuously monitor and trend oxygen delivery (DO₂) that reflects changes in both cardiac output and arterial oxygen content.

Read the original at yf_tkr_DHR ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.